NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
16/06/2021
Voltar para busca
Dado oficial do USPTO
PHARMAPATCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
16/06/2021
Tipo de marca
Mista
Classes Nice
5
Data de depósito
23/07/2009
Data de registro
29/11/2011
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2021
Última transação
16/06/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
01/06/2008
Primeiro uso no comércio
01/06/2008
Código do desenho
3
Tipo de titular
16
Localização do titular
SAN DIEGO, CA
Examinador
WHITTAKER BROWN, TRACY
Unidade examinadora
M20
Localização atual
GENERIC WEB UPDATE
Descrição da marca
The mark consists of an oval carrier outlined in black and dark gray with a curved black and dark gray line running through the middle. Along the inside edge of the oval carrier the color blue turns to light gray in the center. The word "PHARMA PATCH" is presented with the large oval in blue stylized lettering that is outlined in white. "PHARMA" is above the curved line and "PATCH" is below it. To the left of "PHARMA" and to the right of "PATCH" are two small ovals outlined in black. Along the inside edge of both small ovals the color blue turns to light gray in the center.
Titulares e representantes
Titulares
PHARMAPATCH, LLC
Representantes
PHARMAPATCH, LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Transdermal patches for use in the treatment of acnevitamin supplementationimmunitiesstress reductionmosquito repellentskin healing and wrinkles
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/06/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
16/06/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
13/06/2021
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/05/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/05/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
20/01/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
29/11/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/12/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/12/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2017
E815
TEAS SECTION 8 & 15 RECEIVED
07/11/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/11/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
29/11/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
29/11/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/09/2011
PUBO
PUBLISHED FOR OPPOSITION
13/09/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/08/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/07/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/07/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/07/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/06/2011
GNRT
NON-FINAL ACTION E-MAILED
21/06/2011
CNRT
NON-FINAL ACTION WRITTEN
21/06/2011
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
16/06/2011
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
13/06/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/06/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
27/05/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/05/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
27/05/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/05/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/04/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/04/2011
DMCC
DATA MODIFICATION COMPLETED
21/10/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/10/2010
GNRT
NON-FINAL ACTION E-MAILED
20/10/2010
CNRT
NON-FINAL ACTION WRITTEN
20/10/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
20/10/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/10/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
20/10/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/10/2010
DMCC
DATA MODIFICATION COMPLETED
19/10/2010
ALIE
ASSIGNED TO LIE
19/10/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/09/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/09/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/09/2010
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/03/2010
GNFR
FINAL REFUSAL E-MAILED
23/03/2010
CNFR
FINAL REFUSAL WRITTEN
23/03/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/02/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/02/2010
ALIE
ASSIGNED TO LIE
26/02/2010
PAPER RECEIVED
29/01/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/10/2009
GNRT
NON-FINAL ACTION E-MAILED
26/10/2009
CNRT
NON-FINAL ACTION WRITTEN
26/10/2009
DOCK
ASSIGNED TO EXAMINER
26/10/2009
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
28/07/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/07/2009
NWAP
NEW APPLICATION ENTERED
27/07/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARMAPATCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.